Hepatitis B Foundation Welcomes Dr. Robert Gish as Medical Director

Renowned leader in the field of liver disease takes on new role leading advocacy and research.

Doylestown, PA, February 13, 2014 --(PR.com)-- The Hepatitis B Foundation (www.hepb.org), the only national nonprofit organization solely dedicated to finding a cure for hepatitis B, is pleased to announce that Robert G. Gish, M.D., became the foundation’s medical director on Jan. 30, 2014.

An internationally renowned medical researcher in the field of viral hepatitis, Dr. Gish has made invaluable contributions to the understanding and treatment of hepatitis B, which is the world’s leading cause of liver cancer. A longtime supporter of the foundation’s mission and a member of the Scientific Advisory Board, Dr. Gish’s new role will further strengthen its research and advocacy efforts worldwide.

“We are delighted to welcome Dr. Gish to our board,” said Dr. W. Thomas London, senior member emeritus of Fox Chase Cancer Center and vice president of the board of directors of the Hepatitis B Foundation. “He has long been a leader in the field and has extensive experience in the conduct of clinical trials of new drugs to combat chronic hepatitis B. His leadership as medical director will help us advance the treatment and prevent the severe consequences of this potentially deadly disease.”


Labels: ,